(Q42230449)

19 October 2017

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia (English)

1 reference

19 October 2017

J F Bridgman

1

1 reference

19 October 2017

S M Rosen

series ordinal

2

1 reference

19 October 2017

J M Thorp

series ordinal

3

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 September 1972

1 reference

19 October 2017

1 reference

19 October 2017

2

1 reference

19 October 2017

506-509

1 reference

19 October 2017

7776

1 reference

Serum lipid and lipoprotein alterations in nephrosis

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2991905-8

7 January 2021

Plasma protein and lipid pattern in the nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2991905-8

7 January 2021

Hyperlipoproteinaemias in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2991905-8

7 January 2021

Ischemic heart disease, atherosclerosis, and longevity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2991905-8

7 January 2021

RISK FACTORS IN CORONARY HEART DISEASE. AN EVALUATION OF SEVERAL SERUM LIPIDS AS PREDICTORS OF CORONARY HEART DISEASE; THE FRAMINGHAM STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2991905-8

7 January 2021

Ischaemic heart-disease as a complication of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2991905-8

7 January 2021

Clofibrate in perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2991905-8

7 January 2021

Acute Muscular Syndrome Associated with Administration of Clofibrate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2991905-8

7 January 2021

Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2991905-8

7 January 2021

10.1016/S0140-6736(72)91905-8

Identifiers

DOI

1 reference

19 October 2017

1 reference